866-997-4948(US-Canada Toll Free)

China Plasma Protein Therapeutics Market Research Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 123 Pages

Notes:
Sales, means the sales volume of Plasma Protein Therapeutics
Revenue, means the sales value of Plasma Protein Therapeutics

This report studies Plasma Protein Therapeutics in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Baxter International
Biotest
CSL Behring
Grifols, S.A.
Kedrion
Octapharma USA
Shire Plc
China Biologics
Kamada

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
C1 esterase Inhibitors
Albumins
Immunoglobulins
Coagulation Factors
Others
Split by Application, this report focuses on consumption, market share and growth rate of Plasma Protein Therapeutics in each application, can be divided into
Hereditary Angioedema
Hemophilia
Primary Immunodeficiency Disorder
Secondary Immunodeficiency
Idiopathic Thrombocytopenic
Others (Kawasaki disease, GBS, CIDP etc)

Table of Contents

China Plasma Protein Therapeutics Market Research Report 2017
1 Plasma Protein Therapeutics Market Overview
1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Plasma Protein Therapeutics Segment by Type
1.2.1 China Production Market Share of Plasma Protein Therapeutics Type in 2015
1.2.2 C1 esterase Inhibitors
1.2.3 Albumins
1.2.4 Immunoglobulins
1.2.5 Coagulation Factors
1.2.6 Others
1.3 Applications of Plasma Protein Therapeutics
1.3.1 Plasma Protein Therapeutics Consumption Market Share by Application in 2015
1.3.2 Hereditary Angioedema
1.3.3 Hemophilia
1.3.4 Primary Immunodeficiency Disorder
1.3.5 Secondary Immunodeficiency
1.3.6 Idiopathic Thrombocytopenic
1.3.7 Others (Kawasaki disease, GBS, CIDP etc)
1.4 China Market Size (Value) of Plasma Protein Therapeutics (2011-2021)
1.5 China Plasma Protein Therapeutics Status and Outlook
1.6 Government Policies

2 China Plasma Protein Therapeutics Market Competition by Manufacturers
2.1 China Plasma Protein Therapeutics Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Plasma Protein Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Plasma Protein Therapeutics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Plasma Protein Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Plasma Protein Therapeutics Market Competitive Situation and Trends
2.5.1 Plasma Protein Therapeutics Market Concentration Rate
2.5.2 Plasma Protein Therapeutics Market Share of Top 3 and Top 5 Manufacturers

3 China Plasma Protein Therapeutics Manufacturers Profiles/Analysis
3.1 Baxter International
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.1.2.1 C1 esterase Inhibitors
3.1.2.2 Albumins
3.1.3 Baxter International Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Biotest
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.2.2.1 C1 esterase Inhibitors
3.2.2.2 Albumins
3.2.3 Biotest 123 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 CSL Behring
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.3.2.1 C1 esterase Inhibitors
3.3.2.2 Albumins
3.3.3 CSL Behring 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Grifols, S.A.
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.4.2.1 C1 esterase Inhibitors
3.4.2.2 Albumins
3.4.3 Grifols, S.A. Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Kedrion
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.5.2.1 C1 esterase Inhibitors
3.5.2.2 Albumins
3.5.3 Kedrion Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Octapharma USA
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.6.2.1 C1 esterase Inhibitors
3.6.2.2 Albumins
3.6.3 Octapharma USA Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Shire Plc
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.7.2.1 C1 esterase Inhibitors
3.7.2.2 Albumins
3.7.3 Shire Plc Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 China Biologics
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.8.2.1 C1 esterase Inhibitors
3.8.2.2 Albumins
3.8.3 China Biologics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Kamada
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Plasma Protein Therapeutics Product Type, Application and Specification
3.9.2.1 C1 esterase Inhibitors
3.9.2.2 Albumins
3.9.3 Kamada Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview

4 China Plasma Protein Therapeutics Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
4.1 China Plasma Protein Therapeutics Capacity, Production and Growth (2011-2016)
4.2 China Plasma Protein Therapeutics Revenue and Growth (2011-2016)
4.3 China Plasma Protein Therapeutics Production, Consumption, Export and Import (2011-2016)

5 China Plasma Protein Therapeutics Production, Revenue (Value), Price Trend by Type
5.1 China Plasma Protein Therapeutics Production and Market Share by Type (2011-2016)
5.2 China Plasma Protein Therapeutics Revenue and Market Share by Type (2011-2016)
5.3 China Plasma Protein Therapeutics Price by Type (2011-2016)
5.4 China Plasma Protein Therapeutics Production Growth by Type (2011-2016)

6 China Plasma Protein Therapeutics Market Analysis by Application
6.1 China Plasma Protein Therapeutics Consumption and Market Share by Application (2011-2016)
6.2 China Plasma Protein Therapeutics Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaPlasma Protein Therapeutics Market Analysis by Regions (Provinces)
7.1 China Plasma Protein Therapeutics Production, Production Value and Price by Regions (Provinces)(2011-2016)
7.1.1 China Plasma Protein Therapeutics Production and Market Share by Regions (Provinces)(2011-2016)
7.1.2 China Plasma Protein Therapeutics Production Value and Market Share by Regions (Provinces)(2011-2016)
7.1.3 China Plasma Protein Therapeutics Sales Price by Regions (Provinces)(2011-2016)
7.2 China Plasma Protein Therapeutics Consumption by Regions (Provinces)(2011-2016)
7.3 China Plasma Protein Therapeutics Production, Consumption, Export and Import (2011-2016)

8 Plasma Protein Therapeutics Manufacturing Cost Analysis
8.1 Plasma Protein Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Plasma Protein Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Plasma Protein Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Plasma Protein Therapeutics Market Forecast (2016-2021)
12.1 China Plasma Protein Therapeutics Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Plasma Protein Therapeutics Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Plasma Protein Therapeutics Production Forecast by Type (2016-2021)
12.4 China Plasma Protein Therapeutics Consumption Forecast by Application (2016-2021)
12.5 China Plasma Protein Therapeutics Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.5.1 China Plasma Protein Therapeutics Production Forecast by Regions (Provinces)(2016-2021)
12.5.2 China Plasma Protein Therapeutics Consumption Forecast by Regions (Provinces)(2016-2021)
12.5.3 China Plasma Protein Therapeutics Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Plasma Protein Therapeutics Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *